You are here: Industry Insights > anti-epileptic drug

News List

EMA accepts marketing authorisation application for anti-epileptic drug cenobamate europeanpharmaceuticalreview
April 03, 2020
Cenobamate’s application was based on a global clinical trials programme enrolling over 1,900 adults with uncontrolled focal-onset seizures.
Dr Reddy’s launches generic oral anti-epileptic drug in US expresspharma
August 21, 2019
Drug firm Dr Reddy’s Laboratories said it has launched generic anti-epileptic Vigabatrin powder for oral solution in the US market. The product is a generic version of Lundbeck’s Sabril powder for oral solution, Dr Reddy’s said in a filing to the BSE.
Strides Pharma Science arm gets USFDA nod for anti-epileptic drug expressbpd
February 21, 2019
The approved product is a generic version of Zarontin Capsules, 250 mg, of Pfizer
UCB receives EU approval for paediatric anti-epileptic drug europeanpharmaceuticalreview
September 25, 2017
UCB has announced that the European Commission has approved the use of its anti-epileptic drug Vimpatas in the treatment of partial-onset seizures…
Aurobindo Pharma gets US FDA nod for its anti-epileptic drug and to acquire Portugal’s Generis for € firstwordpharma
January 09, 2017
Aurobindo Pharma has been granted final FDA approval to launch a generic version of HQ Specialty Pharma's epilepsy drug levetiracetam, livemint.com reported, Aurobindo Pharma to acquire Portugal’s Generis for €135 million.